Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Qvanteq
company
About
Qvanteq is a medtech startup company, developing surface technology that can be applied onto any coronary stent.
- 1 - 10
Highlights
Details
- Last Funding Type
- Seed
- Industries
- Biotechnology,Developer Platform,Medical
- Founded date
- Jan 1, 2009
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Qvanteq is a medtech startup company, developing novel bioactive stents to address and overcome the clinical adverse effects of today’s available coronary and endovascular stents. Its bioactive Qstent controls in-growth therefore reducing the risk of restenosis and thrombosis. The company was awarded with the CTI start-up label in 2012.Qvanteq was founded in 2009 and is held by private investors. The ISO 13485 certified company is based in Zürich, Switzerland. It is a spin-off company from the Swiss Federal Institute of Technology, Zurich.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Qvanteq has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Apr 27, 2010 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 27, 2010 | Seed | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Qvanteq is funded by 1 investors.
Verve Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Verve Ventures
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
